Cancer marker profile Liver-2
Sample Type
Recommended for
Report
Liver cancer is cancer of the liver cells (hepatocytes). Hence, it is also known as Hepatocellular cancer. The diagnosis is often by cancer marker tests. Cancer markers or tumour markers are proteins produced by the normal cells as well as cancer cells, but are produced in higher levels by the cancer cells. Cancer marker Profile Liver-2 consists of tests to measure the levels of tumour markers in the blood, urine, and other body fluids. This profile test is used with other tests to screen for liver cancer and decide the best treatment.
Price : ₹ 6,095
The Cancer Marker profile Liver-2 measures the AFP, CEA, CA 19.9, Chromogranin A levels in the blood.
- To screen for Liver cancers: This may include patients with suspected clinical signs and symptoms of liver cancer.
- For monitoring treatment and relapse in patients with pancreatic adenocarcinoma.
- The test may be used as a prognostic marker for survival following bile duct, pancreatic or gall bladder surgery.
- In patients diagnosed with liver cancer: To know the stage of cancer as well as the metastasis status
- The test can help detect recurrence, metastasis and residual cancer: This may even include patients with a history of cancer of other organs like breast, lung, pancreas, gall bladder etc.
Primary liver cancer being relatively uncommon, often goes undetected due to the lack of specific signs and symptoms. Some symptoms that may require further testing may include:
- Right abdominal pain.
- Jaundice (yellowing of eyes and skin)
- White chalky stools
- Loss of appetite
- Abnormal weight loss with malaise.
- Abdominal bloating
- History of liver cirrhosis
- Chronic Hepatitis infection
This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.
